Pharmacopuncture for Aromatase Inhibitor Induced Arthralgia (AIA) | MicrobiomeTrials← Back to trialsNCT07789717
Pharmacopuncture for Aromatase Inhibitor Induced Arthralgia (AIA)
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2026-01-05Est. Completion: 2027-12-31
Enrollment target: 30 participants Locations- Daejeon University Daejeon Korean Medicine Hospital, Daejeon, Daejeon, South Korea
- Cha Ilsan Medical Center, Goyang-si, Gyeonggi-do, South Korea
- Catholic Kwandong University International St. Mary's Hospital, Incheon, Incheon, South Korea
Other microbiome trials you might be interested in
Triple-Negative Breast Cancer
This is a randomized, open-label study comparing the efficacy and safety of adjuvant sacituzumab tirumotecan (MK-2870) i…
Mobile, United StatesEst. completion Dec 16, 2030
BREAST CANCER
A PROSPECTIVE, MULTI-CENTER, PHASE 4, SINGLE ARM STUDY TO ASSESS THE SAFETY OF TRASTUZUMAB DERUXTECAN, AN ANTI-HER2-ANTI…
Bangalore, IndiaEst. completion Oct 31, 2026
Recruiting
In this study, a randomized controlled study was conducted between two groups of 40 recipients of conventional flap duri…
Busan, South KoreaEst. completion Jun 30, 2024